Insider Selling: HeartWare International Insider Unloads 2,179 Shares of Stock (HTWR)
HeartWare International (NASDAQ:HTWR) Insider Jeffrey Larose sold 2,179 shares of the stock on the open market in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $92.82, for a total value of $202,254.78. Following the transaction, the insider now directly owns 20,267 shares in the company, valued at approximately $1,881,183. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
HTWR has been the subject of a number of recent research reports. Analysts at JPMorgan Chase & Co. raised their price target on shares of HeartWare International from $125.00 to $131.00 in a research note to investors on Monday, December 16th. Separately, analysts at Canaccord Genuity raised their price target on shares of HeartWare International from $110.00 to $115.00 in a research note to investors on Tuesday, December 3rd. Finally, analysts at CRT Capital initiated coverage on shares of HeartWare International in a research note to investors on Tuesday, November 26th. They set a “buy” rating and a $109.00 price target on the stock. Two analysts have rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company’s stock. HeartWare International has an average rating of “Hold” and an average price target of $98.58.
Shares of HeartWare International (NASDAQ:HTWR) traded up 1.23% during mid-day trading on Friday, hitting $95.98. The stock had a trading volume of 122,834 shares. HeartWare International has a one year low of $69.31 and a one year high of $99.68. The stock has a 50-day moving average of $92.96 and a 200-day moving average of $85.63. The company’s market cap is $1.580 billion.
HeartWare International (NASDAQ:HTWR) last released its earnings data on Thursday, November 7th. The company reported ($0.69) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.83) by $0.14. The company had revenue of $54.80 million for the quarter, compared to the consensus estimate of $49.40 million. On average, analysts predict that HeartWare International will post $-3.11 earnings per share for the current fiscal year.
Heartware International, Inc (NASDAQ:HTWR) develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of advanced heart failure.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.